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Detection of epithelial cancer cells in peripheral blood by reverse
transcriptase-polymerase chain reaction
SA Burchill, MF Bradbury, K Pittman, J Southgate, B Smith and P Selby
ICRF Cancer Medicine Research L'nit and Candlelighters Children's Cancer Research Laboratory, Centre for Cancer Research,
Leeds Research School of Mfedicine, St James's Universit,y Hospital, Leeds LS9 7TF, UK.
Summun- Circulating cancer cells in the blood play a central role in the metastatic process. Their numbers
can be very small and techniques for their detection need to be both sensitive and specific. Polymerase chain
reaction (PCR) has been successfully used to detect small numbers of tumour cells in haematological cancers.
in which abnormalities in DNA are sufficiently consistent to make this possible. For most solid tumours this is
not yet feasible. However. we have found that reverse transcriptase (RT) PCR for tissue-specific gene
expression is a useful technique for identifying small numbers of circulating cells in melanoma and neuroblas-
toma patients. In this report we describe detection of colon carcinoma cells by RT-PCR using CK 20 mRNA
as a marker. Unlike other cytokeratin genes examined (CK 8 and CK 19). CK 20 was not transcribed in
normal haematopoietic cells. This suggests a role for RT-PCR in the detection of colon carcinoma metastasis
in blood and bone marrow. using CK 20 as the target gene. Future analysis of clinical matenral will determine
the clinical significance of this technique.
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Intermediate filaments (IFs) are primary components of
mammalian cell cytoskeleton and constitute a multigene
family of proteins distinguished by their cell type-specific
expression (reviewed by Nagle. 1988). The cytokeratins
(CKs), which comprise some 20 different isotypes. are pre-
dominantly expressed in epithelial cells, where they show
strict lineage- and differentiation-associated patterns of ex-
pression (Moll et al., 1982; Sun et al., 1984). Malignant cells
generally retain the IFs of their progenitor cell type and
consequently CKs have been used to characterise neoplastic
cells of epithelial origin (Osborn and Weber. 1983: Cooper et
al., 1985; Lane and Alexander. 1990).
Some circulating tumour cells result in metastasis and so
may have a major influence on patient prognosis. Since the
number of circulating cells may be very small, methods for
their detection need to be both sensitive and specific. We
have used the method of reverse transcriptase-polymerase
chain reaction (RT-PCR) to detect both melanoma (Smith
et al., 1991) and neuroblastoma (Burchill et al.. 1994) tumour
cells in patient blood samples. The success of this technique
is dependent on the availability of a specific target which can
distinguish tumour cells from haematopoietic cells. As CKs
are expressed in a tissue-specific manner by epithelial cells,
we have examined the possible use of CK 8. CK 19 and CK
20 genes as targets for RT-PCR detection of disseminating
disease in carcinomas. CK 8 and CK 19 were targeted as
they are widely expressed by mucosal epithelial tissues (Moll
et al., 1982; Sun et al., 1984) and CK 20 was selected as a
more discriminatory marker, particularly of cells of gastro-
intestinal derivation (Moll et al.. 1992, 1993).
Materials and methods
Cell lines
The three well-characterised human cell lines used in the
study were the transitional cell carcinoma-derived RTI 12 cell
line, the breast adenocarcinoma MCF-7 cell line and the
colonic adenocarcinoma HT29 cell line. MCF-7 and HT29
cells express CK 8, CK 18 and CK 19 (Moll et al., 1982),
whereas RT112 expresses CK 8, CK 18, CK 19 along with
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other CK isotypes characteristic of bladder epithelial cells
(Wu et al., 1982). CK 20, the most recently identified CK
isotype, is expressed by HT29 cells, but not by MCF-7 cells
(Moll et al., 1992). All cell lines were maintained in a 1:1
mixture of Dulbecco's modified Eagle medium (DMEM) and
RPMI-1640 media supplemented with 5% fetal bovine serum
and passaged using 0.25% trypsin in versene (0.02%
EDTA).
Blood and bone marrow samples
Normal blood or bone marrow samples were obtained from
volunteers aged between 18 and 45 years. Samples were taken
into EDTA, aliquoted into 2 ml volumes and frozen at
- 80C until required for RNA extraction.
RNA extraction
Total cellular RNA was extracted from cell lines. normal
whole blood, normal bone marrow or spiked normal blood
using Ultraspec RNA (Biogenesis, Bournemouth, UK) ac-
cording to the manufacturer's instructions.
Reverse transcriptase-polvmerase chain reaction (RT-PCR)
The RT-PCR method used was based on that for the detec-
tion of neuroblastoma cells (Burchill et al., 1994). Briefly,
dilution curves of RNA were DNAse treated and reverse
transcribed to produce cDNA using a random hexamer
primer. RT products were amplified by PCR for CK 8, CK
19 or CK 20 (primer sequences are given in Table I).
RT-PCR products were analysed by agarose gel electro-
phoresis and ethidium bromide staining. Reverse transcrip-
tase negative controls (RT -ve) in which reverse transcrip-
tase enzyme was omitted were included for all RT-PCR
reactions. Water negative controls (W) contained all com-
ponents for the RT-PCR reaction but no target RNA.
Where appropriate, positive controls (+ C) of RNA extracted
from HT29, MCF7 or RTI 12 cells were included. Molecular
weight markers (qpX 1 74RF DNA/HaeIII, Gibco BRL,
Paisley. UK, or 123 bp ladder, Pharmacia, Milton Keynes,
UK) were included on all agarose gels.
The quality of RNA was confirmed by amplification of
cDNA for glyceraldehyde phosphate dehydrogenase
(GAPDH) or 18S probed Northern blot analysis. All primers
were purchased from Oswell DNA Services (Edinburgh,
UK).
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Table I Primer sequences used for PCR amplification of CK 8. CK 19 and CK 20
Sense primer Antisense priner
CK 8
CK 19
CK 20
AACAACCTlAGGCGGCAGCTF GCCTGAGGAAGTTGATCTCG
GCGGGACAAGATTCTTGGTG CTUCAGGCC-TUCGATCTGCAT
CAGACACACGGTGAACTATGG GATCAGCTTCCACTGTTAGACG
Primer sequences for PCR were selected using the Dieffenbach Selection Programme. Primers
were located within different exons and were either 20-. 21- or 22-mers.
Specificitv of RT-PCR
RT-PCR products were separated on agarose gels and
Southern blotted onto nylon membrane (Hybond N+, Amer-
sham, UK). Filters were hybridised with a gamma 32P end-
labelled oligonucleotide probe, the sequence of which lay
between each primer set. The nucleotide sequence of RT-
PCR products was confirmed by dideoxy chain termination
sequencing (Sequenase, USS, Canada).
Cell spiking
Cell spiking experiments were used to test the potential sen-
sitivity of this technique for detection of colon carcinoma
cells in blood. Known numbers of HT29 cells were added to
whole blood samples, mRNA extracted and RT-PCR for
CK 20 performed. To 2 ml aliquots of whole blood 10 to
I x 1O0 cells were added; an unspiked blood sample was
included in each experiment. RNA (100 pg) from HT29 cells
was included as a positive control.
Results
RT- PCR detection of bladder, breast and colon carcinoma
cells
RT-PCR for CK 8 generated a single 244 bp band identified
on ethidium bromide-stained agarose gels (Figure la). This
fragment was confirmed by Southern blot analysis and
sequencing (data not shown) to be the fragment of CK 8
which lies between the two primers used for PCR. The band
was detected in 10 pg to 100 ng of total RNA from RTI 12
cells.
RT-PCR for CK 19 generated a single 214 bp band
identified on ethidium bromide-stained agarose gels (Figure
I b) which was confirmed to be CK 19 by Southern blot
analysis and sequencing (data not shown). This band was
detected in 1lOpg to I ng of total RNA from MCF7
cells.
RT-PCR for CK 20 geneated a single band of 370 bp
(Figure lc). This band was confirmed by Southern hybridisa-
tion and sequence analysis (data not shown) and detected in
100 pg of total RNA from HT29 cells.
In all three cases there was an increase in band intensity
with increasing amounts of RNA (Figure 1). No transcripts
were identified in water control samples (Figure 1) or RT-
negative samples (results not shown).
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Figure I Products of RT-PCR for CK 8. 19 and 20 mRNA on
I pg to 100 ng of total mRNA isolated from RT1 12 (CK 8),
MCF7 (CK 19) and HT29 (CK 20) cell lines. A single band of
244. 214 and 370 bp respectively was identified after separation of
products in an agarose gel and staining with ethidium bromide.
There was an increase in the intensity of this band with increas-
ing RNA concentration. M. molecular weight markers; W, water
control.
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Control blood and bone marrow analisis
In 8 9 and 6 15 control blood samples analysed CK 8 and
CK 19 RT-PCR products were identified under the des-
cribed conditions. Southern blotting confirmed that amplified
bands were CK 8 and CK 19 RT-PCR products (results not
shown). In 15 15 control blood samples analysed, CK 20 was
undetectable by ethidium bromide staining or Southern blot
hybridisation. RT-PCR results for CK 8 (Figure 2a). CK 19
(Figure 2b) or CK 20 (Figure 2c) are shown for six control
bloods: 6 6 were positive for CK 8. 3 6 for CK 19 and 0 6
for CK 20.
RT-PCR for CK 20 in 6 6 normal bone marrow samples
showed no amplified bands (Figure 3a). The integrity of bone
marrow RNA samples was confirmed by RT-PCR for
GAPDH (Figure 3b).
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Figure 2 Products of RT-PCR for CK 8 (a) 19 (b) and 20 (c)
mRNA separated by agarose gel electrophoresis and stained with
ethidium bromide in six control bloods (1 -6). C. positive control
for CK 8. 19 or 20 mRNA detection; W. water negative control;
M. molecular weight markers.
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Fire 3 Products of RT-PCR for CK 20 mRNA separated by
electrophoresis, and stained with ethidium bromide in six control
bone marrow samples a, RT-PCR for GAPDH in the same
RNA samples (b). +C, positive control of RNA extracted from
HT29 cells; W. water negative control; M, molecular weight
markers.
Cell spiking
In HT29 cell spiking experiments it was possible to detect
down to 100 HT29 cells diluted in 2 ml of whole human
blood (Figure 4a). The 370 bp band generated was shown by
Southern blotting to hybridise to a 32P end-labelled oligo-
nucleotide probe specific for CK 20 and confirmed by
sequence analysis to be that of CK 20 (results not shown).
No RT-PCR products were detected in whole blood alone
(Figure 4a, 0). RT-PCR products were not identified in
reverse transcriptase-negative samples (Figure 4b).
The expression of cytokeratins by epithelial tissues and their
expression following neoplastic transformation had made
them reliable markers in diagnostic surgical pathology. We
have looked at the possible use of CKs as targets for
RT-PCR detection of metastasising tumour cells of epithe-
lial origin.
Since CK 8 and CK 19 were expressed in a high propor-
tion of normal peripheral blood samples (88% and 40%
respectively), neither would be suitable targets for detection
of tumour cells in peripheral blood. These findings for CK 8
confirm the findings of Traweek et al. (1993), though no CK
19 expression was reported by Traweek et al. (1993) in bone
marrow or peripheral blood. This is in contrast to the find-
ings reported here. The number of normal peripheral blood
samples analysed in this study was greater than in the study
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Fige 4 Products of RT-PCR for CK 20 mRNA separated by
agarose gel electrophoresis and stained with ethidium bromide in
blood samples spiked with I -10 HT29 cells. A single 370 bp
band was identified when as few as 100 cells per ml of whole
blood were analysed (3). No band was identified in unspiked
blood (0). RT-negative samples showed no amplified band (b).
+ C, positive control of RNA extracted from HT29 cells; W.
water negative control; M, molecular weight markers.
of Traweek et al.. which may explain the discrepancy in
results. The presence of CK 19 pseudogenes (Bader et al.,
1986; Savtchenko et al., 1988) further complicates interpreta-
tion of data using CK 19. Datta et al. (1994) have recently
reported on the use of CK 19 for the detection of breast
carcinoma micrometastasis using primer sequences selected to
incorporate differences between CK 19 and pseudogene at
the 3' end. This would not exclude amplification of other CK
19 pseudogenes that do not differ at the 3' end and would
limit the value of CK 19 for this purpose.
CK 20 mRNA was not detected in any normal blood or
bone marrow samples examined, suggesting it to be the CK
of choice for detection of some carcinomas of epithelial
origin. CK 20 has been detected in almost all cases of
colorectal adenocarcinomas by immunohistochemistry (Moll
et al., 1987) and may prove to be a useful target for the
detection of disseminating colon carcinoma by RT-PCR. To
evaluate further the clinical value of CK 20 as a target gene
for the detection of colorectal carcinoma metastatic cells we
are examining expression of CK 20 in blood and bone mar-
row samples from patients.
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